Shirley Wang, PhD, ScM
Brigham and Women's Hospital
51
51
49
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+49 more interventions
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (20)
Showing 10 of 20 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Nils Krüger, MD
Brigham and Women's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Denys Shay, MD
Brigham and Women's Hospital
Shared therapeutic areas:
Worked with same sponsors:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Andrea Natale, MD
Texas Cardiac Arrhythmia Research Foundation
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Urielle Desalbres
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
David s Ludwig, MD, PhD
Boston Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Samuel Klein, MD
Washington University School of Medicine
Shared therapeutic areas:
Mark Levine, MD
Ontario Clinical Oncology Group (OCOG)
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (51)
Showing 20 of 51 trials
Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases
Emulation of the KEYNOTE-042 (NCT02220894) Trial Using Specialty Oncology Electronic Health Records Databases
Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.
Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)
Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk
Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
Emulation of the MONALEESA-2 Trial Using Specialty Oncology Electronic Health Records Databases
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data
Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records Databases
Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
Emulation of the SOUL Diabetes Trial in Healthcare Claims
Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims Data
Emulation of the EMPEROR-Reduced Trial Using Healthcare Claims Data